IMRF
IOVA icon

Illinois Municipal Retirement Fund’s Iovance Biotherapeutics IOVA Stock Holding History

Illinois Municipal Retirement Fund’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,135
Closed -$289K – 863
2021
Q1 		$289K Hold
9,135
– – 0.01% 815
2020
Q4 		$424K Buy
9,135
+4,570
+100% +$181K 0.02% 682
2020
Q3 		$150K Buy
+4,565
New +$140K 0.02% 718

Other funds holding IOVA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Illinois Municipal Retirement Fund's IOVA Position: Q2 2021 in Review

Illinois Municipal Retirement Fund sold out of Iovance Biotherapeutics (IOVA) in Q2 2021, closing a stake of 9,135 shares — an estimated $289K sold.

Illinois Municipal Retirement Fund first reported a position in IOVA in Q3 2020 and held it in 3 quarters. The position peaked at $424K in Q4 2020. 233 funds tracked by Wall St. Rank hold IOVA as of Q2 2021.

  • Illinois Municipal Retirement Fund reported no remaining Iovance Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • Illinois Municipal Retirement Fund sold 9,135 Iovance Biotherapeutics shares in Q2 2021, an estimated $289K.
  • Illinois Municipal Retirement Fund first reported a position in Iovance Biotherapeutics in Q3 2020 and held it in 3 quarters.
  • Illinois Municipal Retirement Fund's Iovance Biotherapeutics position peaked at $424K in Q4 2020.
  • 233 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2021.

Based on Illinois Municipal Retirement Fund's 13F filing for Q2 2021, filed 4 Aug 2021.